In addition, there are also identifying markers of early response in lung cancer, such as the TCR repertoire, the CD4+/CD8+ T cell profile, the cytokine signature, and immune checkpoint molecule expression in tumour cells, macrophages or T cells [42]. This evidence concerns the gene CD8A and lung cancer.